Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin Infusion Rates in Elective Cesarean Delivery
NCT01932060Phase 3Completed
- Sponsor
- Stanford University
- Start
- Aug 2013
- Primary completion
- Sep 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of oxytocin in postpartum hemorrhage (PPH) (2 arms), sponsored by Stanford University. Primary endpoint: Total Estimated Blood Loss. Started Aug 2013; status: completed.
02
Drugs
oxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT01932060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01932060.